Phase Space AI

Trade Construction

ExlService Holdings [EXLS]

ExlService Holdings [EXLS] — Trade Construction

As of 2026-07-30 · spot $34.71 · The memo issues no position verdict; the book decides.

Timing note — this is a post-print entry

EXLS reported Q2 2026 on 2026-07-28 and the stock rose +18.3% on 2026-07-29 ($30.515 → $36.085), then gave back 3.8% to $34.71. Anyone acting on this memo is buying after the news that raised organic guidance from 10–12% to 13–14%. That is stated plainly because the +21.4% target is measured from a price that already contains the beat.

Vehicle: EQUITY

• A LEAP requires measured IV minus trailing 252-day realised vol. Realised 252-day vol is 41.4% (screen record) and the stock just moved 18% in a session, so realised vol is rising. Options IV was NOT measured within the time-box — the spread is UNMEASURED and cannot carry the argument. Per the brief, absent an argument the vehicle is equity.
• A shorter-dated structure would need a catalyst preceding expiry. Q3 2026 results, expected late October 2026, qualify — that is the first print containing iMerit and the first test of whether the DSO deterioration continues. Stated so the book can use it; not proposed, because the IV to price it was not measured.
• Multi-leg requires constructability at the strike with quoted size. Not quoted. Not proposed.

Sizing

• Market cap $5.3bn — mid. No admission constraint.
• Net debt is 1.8% of EV. The equity is essentially the enterprise; there is no gearing amplification. This is the cleanest capital structure of the three names in the cluster (PRGS 42.0%, PTC 6.4%, EXLS 1.8%) and it means the equity vol is the business vol.
• The iMerit acquisition closes 2026-07-31. Consideration is not disclosed in the Q2 release, so the pro-forma net debt is unknown as of this memo. Sizing should assume net debt rises.

Levels

Invalidation, named and measurable — any one of: 1. Organic revenue growth guidance falls below ~8%. Currently guided 13–14%; the required path is 4.1%. Below 8% the buffer that makes this the most robust of the three tests is gone. 2. Digital operations decline steepens beyond ~−5%. It is −1.5% now. This is the line that distinguishes "mix shift" from "AI is eating our revenue" — the named downside cause. 3. Same-quarter DSO exceeds ~72 days, or any receivables-sale, factoring or securitisation programme appears in a filing. Today: 66.5 days and zero factoring language. The second half of that condition matters as much as the first — per the CLS precedent, a receivables programme would make the DSO improve while collections worsened. 4. Top-10 client concentration rises above ~38%, or any single client crosses 10%. Stable at 33–34% for three years. 5. Price through $31.32, the window-B multiple low, which is also below the pre-print price.

Asymmetry

+21.4% base against −9.8% at the company's own post-2024 multiple low. That is roughly 2:1 on a name whose valuation test has no flip point inside any plausible multiple range — it still passes at 10.1x, below anything it has traded at since 2024. Of the three names in this cluster, EXLS is the only one where the upside does not depend on the multiple doing the work.